Whereas the enrichment of CCR2+ macrophages has been observed in PDAC after radiotherapy, neutralizing or genetic depletion of CCL2 improves radiotherapy responses and attenuates tumor growth in mouse models [99]. This evidence concerns the gene CCR2 and neoplasm.